 "Torrent Pharma")
Torrent Pharma Photo: Shutterstock
Torrent Pharmaceuticals on Friday reported a 26.2 per cent jump in its consolidated net profit to ₹635 crore in the third quarter of the financial year 2025-26 (Q3FY26). During the same quarter last year, the company recorded a profit of ₹503 crore. On a sequential basis, profit increased 7.4 per cent from ₹591 crore. The company attributed the surge to robust branded business performance across markets.
The company’s revenue from operations from the quarter increased 17.7 per cent year-on-year (Y-o-Y) to ₹3,251 crore from ₹2,762 crore in Q3FY25. Sequentially, the revenue was flat from ₹3,246 crore.
Its earnings before interest, taxes, depreciation and amortisation (Ebitda) for the quarter stood at ₹1,088 crore, up 17 per cent Y-o-Y.
Torrent Pharma dividend announced
Torrent Pharma also announced an interim dividend of ₹29 per share. “The dividend is expected to be paid/dispatched on or around March 5, 2026,” it added.
First Published: Feb 13 2026 | 5:40 PM IST
Discover more from News Link360
Subscribe to get the latest posts sent to your email.
